These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11924458

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Painful sequelae of injuries to peripheral nerves.
    Yiannikas C, Shahani BT.
    Am J Phys Med; 1984 Apr; 63(2):53-83. PubMed ID: 6324596
    [No Abstract] [Full Text] [Related]

  • 3. Neuropathic pain in leprosy.
    Haanpää M, Lockwood DN, Hietaharju A.
    Lepr Rev; 2004 Mar; 75(1):7-18. PubMed ID: 15072122
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D, Attal N, Morain F, Bouhassira D.
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [Abstract] [Full Text] [Related]

  • 7. Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components.
    Morlion B.
    Curr Med Res Opin; 2011 Jan; 27(1):11-33. PubMed ID: 21083513
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Microneurography: an opportunity for translational drug development in neuropathic pain.
    Serra J.
    Neurosci Lett; 2010 Feb 19; 470(3):155-7. PubMed ID: 20045040
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. What can we learn from failed neuropathic pain trials?
    Polydefkis M, Raja SN.
    Neurology; 2008 Jan 22; 70(4):250-1. PubMed ID: 18209199
    [No Abstract] [Full Text] [Related]

  • 15. Refractory neuropathic pain: the nature and extent of the problem.
    Niv D, Devor M.
    Pain Pract; 2006 Mar 22; 6(1):3-9. PubMed ID: 17309703
    [No Abstract] [Full Text] [Related]

  • 16. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
    Yucel A, Ozyalcin S, Koknel Talu G, Kiziltan E, Yucel B, Andersen OK, Arendt-Nielsen L, Disci R.
    Eur J Pain; 2005 Aug 22; 9(4):407-16. PubMed ID: 15979021
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Botulinum toxin type A treatment of painful focal neuropathies: new evidence for efference of afferents.
    Murinson BB.
    Ann Neurol; 2008 Sep 22; 64(3):236-8. PubMed ID: 18825659
    [No Abstract] [Full Text] [Related]

  • 19. Leading the charge--pioneering treatments in the fight against neuropathic pain.
    Dickinson T, Lee K, Spanswick D, Munro FE.
    Trends Pharmacol Sci; 2003 Nov 22; 24(11):555-7. PubMed ID: 14607072
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacological treatment of neuropathic pain].
    Sindrup SH.
    Tidsskr Nor Laegeforen; 2004 Mar 04; 124(5):637-8. PubMed ID: 15004608
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.